Empirically based comparisons of the reliability and validity of common quantification approaches for eyeblink startle potentiation in humans

por Bradford, Daniel E., Starr, Mark J., Shackman, Alexander J., Curtin, John J.
Publicado 2015

Alcohol’s effects on emotionally motivated attention, defensive reactivity and subjective anxiety during uncertain threats

por Bradford, Daniel E, Motschman, Courtney A, Starr, Mark J, Curtin, John J
Publicado 2017

Role of TGF-β receptor III localization in polarity and breast cancer progression

por Meyer, Alison E., Gatza, Catherine E., How, Tam, Starr, Mark, Nixon, Andrew B., Blobe, Gerard C.
Publicado 2014

The Balance of Cell Surface and Soluble Type III TGF-β Receptor Regulates BMP Signaling in Normal and Cancerous Mammary Epithelial Cells()

por Gatza, Catherine E., Elderbroom, Jennifer L., Oh, Sun Young, Starr, Mark D., Nixon, Andrew B., Blobe, Gerard C.
Publicado 2014

Ectodomain shedding of TβRIII is required for TβRIII-mediated suppression of TGF-β signaling and breast cancer migration and invasion

por Elderbroom, Jennifer L., Huang, Jennifer J., Gatza, Catherine E., Chen, Jian, How, Tam, Starr, Mark, Nixon, Andrew B., Blobe, Gerard C.
Publicado 2014

Correlation of angiogenic biomarker signatures with clinical outcomes in metastatic colorectal cancer patients receiving capecitabine, oxaliplatin, and bevacizumab

por Liu, Yingmiao, Starr, Mark D, Bulusu, Anuradha, Pang, Herbert, Wong, Nan Soon, Honeycutt, Wanda, Amara, Anthony, Hurwitz, Herbert I, Nixon, Andrew B
Publicado 2013

Modulation of circulating protein biomarkers following TRC105 (anti-endoglin antibody) treatment in patients with advanced cancer

por Liu, Yingmiao, Starr, Mark D, Brady, John C, Dellinger, Andrew, Pang, Herbert, Adams, Bonne, Theuer, Charles P, Lee, Nam Y, Hurwitz, Herbert I, Nixon, Andrew B
Publicado 2014

Pilot investigation of circulating angiogenic and inflammatory biomarkers associated with vascular malformations

por Wetzel-Strong, Sarah E., Weinsheimer, Shantel, Nelson, Jeffrey, Pawlikowska, Ludmila, Clark, Dewi, Starr, Mark D., Liu, Yingmiao, Kim, Helen, Faughnan, Marie E., Nixon, Andrew B., Marchuk, Douglas A.
Publicado 2021

A phase I study of ABT-510 plus bevacizumab in advanced solid tumors

por Uronis, Hope E, Cushman, Stephanie M, Bendell, Johanna C, Blobe, Gerard C, Morse, Michael A, Nixon, Andrew B, Dellinger, Andrew, Starr, Mark D, Li, Haiyan, Meadows, Kellen, Gockerman, Jon, Pang, Herbert, Hurwitz, Herbert I
Publicado 2013

Blood‐based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance)

por Hatch, Ace J., Sibley, Alexander B., Starr, Mark D., Brady, J. Chris, Jiang, Chen, Jia, Jingquan, Bowers, Daniel L., Pang, Herbert, Owzar, Kouros, Niedzwiecki, Donna, Innocenti, Federico, Venook, Alan P., Hurwitz, Herbert I., Nixon, Andrew B.
Publicado 2016

Evaluating immune response and metabolic related biomarkers pre-allogenic hematopoietic stem cell transplant in acute myeloid leukemia

por Siamakpour-Reihani, Sharareh, Cao, Felicia, Lyu, Jing, Ren, Yi, Nixon, Andrew B., Xie, Jichun, Bush, Amy T., Starr, Mark D., Bain, James R., Muehlbauer, Michael J., Ilkayeva, Olga, Byers Kraus, Virginia, Huebner, Janet L., Chao, Nelson J., Sung, Anthony D.
Publicado 2022

Reciprocal SOX2 regulation by SMAD1-SMAD3 is critical for anoikis resistance and metastasis in cancer

por Shonibare, Zainab, Monavarian, Mehri, O’Connell, Kathleen, Altomare, Diego, Shelton, Abigail, Mehta, Shubham, Jaskula-Sztul, Renata, Phaeton, Rebecca, Starr, Mark D., Whitaker, Regina, Berchuck, Andrew, Nixon, Andrew B., Arend, Rebecca C., Lee, Nam Y., Miller, C. Ryan, Hempel, Nadine, Mythreye, Karthikeyan
Publicado 2022